University of Pittsburg/ Magee-Womens Hospital
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Diego, Emilia
HERO, NCT05705401: Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

Recruiting
3
1300
US
Standard of Care Adjuvant Breast Radiation, Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
NRG Oncology, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group, SWOG Cancer Research Network
HER2-positive Breast Cancer
02/34
02/37
PROMISE, NCT02694809: The Study: Duavee in Women With DCIS

Completed
2
142
US
Conjugated Estrogens/Bazedoxifene, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, placebo therapy, PLCB, sham therapy, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Northwestern University, National Cancer Institute (NCI), Pfizer, University of Chicago - Department for Cancer Research, University of California, San Francisco
Ductal Breast Carcinoma In Situ, Postmenopausal
06/24
06/24
NCT06218303: Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Recruiting
1
50
US
MUC1 Peptide Vaccine, Hiltonol®, POLY-ICLC, Aromatase Inhibitor, Anastrozole (Arimidex), Letrozole (Femara), Exemestane (Aromasin)
Finn, Olivera, PhD, A Glimmer of Hope Foundation, Breast Cancer Research Foundation
Ductal Carcinoma in Situ
01/26
08/28
NCT02945579: Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Recruiting
N/A
120
US
External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiotherapy, External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Whole Breast Irradiation
M.D. Anderson Cancer Center, National Cancer Institute (NCI), Artidis
Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma, Progesterone Receptor Negative, Stage I Breast Cancer AJCC V7, Stage IA Breast Cancer AJCC V7, Stage IB Breast Cancer AJCC V7, Stage II Breast Cancer AJCC V6 and V7, Stage IIA Breast Cancer AJCC V6 and V7, Stage IIB Breast Cancer AJCC V6 and V7, Triple-Negative Breast Carcinoma
01/26
01/26

Download Options